Reversion From Chronic Migraine to Episodic Migraine in Patients Treated With Fremanezumab: Post Hoc Analysis From HALO CM Study

BACKGROUND: Migraine preventive medications are used to reduce headache frequency, severity, and duration. In patients with chronic migraine (CM), reversion to episodic migraine (EM) is an important treatment goal. OBJECTIVE: To evaluate the effect of fremanezumab on the rate of reversion from CM to...

Descripción completa

Detalles Bibliográficos
Autores principales: Lipton, Richard B., Cohen, Joshua M., Bibeau, Kristen, Galic, Maja, Seminerio, Michael J., Ramirez Campos, Verena, Halker Singh, Rashmi B., Ailani, Jessica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Submissions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756262/
https://www.ncbi.nlm.nih.gov/pubmed/33179323
http://dx.doi.org/10.1111/head.13997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756262/
https://www.ncbi.nlm.nih.gov/pubmed/33179323
http://dx.doi.org/10.1111/head.13997

Ejemplares similares